Related Experiment Video
Updated: Dec 27, 2025

Isolation, Transfection, and Culture of Primary Human Monocytes
Published on: December 16, 2019
Severe Immune Thrombocytopenia in a Patient with HIV-HCV Co-infection: Challenges in Management
Vettakkara Kandy Muhammed Niyas1, Vishakh C Keri1, Jatin Ahuja1
1Senior Resident.
Abstract:
Immune thrombocytopenia is a well-known complication of both HIV and Hepatitis C virus infections. Management becomes challenging when a patient with HCV-HIV co-infection presents with severe thrombocytopenia. Adverse drug reactions and drug interactions has to be considered while choosing treatment options for such patients. We report such a case which illustrates the difficulty in managing severe thrombocytopenia in HCV-HIV co-infected patients where evidence based clinical decision making helped in choosing the right therapy for the patient.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Venous Thrombosis III: Interprofessional Care
Sexually Transmitted Infections
Retrovirus Life Cycles
Endocarditis III: Medical Management

